Search Results for: Accutane

Featured Stories
FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Jury Orders Roche to Pay $1.5 Million to Accutane User for IBD

A woman who developed inflammatory bowel disease (IBD) after taking Hoffman-LaRoche’s acne drug Accutane, has been awarded more than $1.5 million in compensatory damages and medical expenses. This was a retrial of the case; an earlier verdict was overturned on … Continue reading

Posted in Accutane, Health Concerns, Legal News, Pharmaceuticals |

Two Accutane Users Awarded $9 Million Each in Inflammatory Bowel Disease Lawsuit

A New Jersey jury has ordered the maker of Accutane to pay a total of $18 million to two people who developed inflammatory bowel diseases while using the drug.  According to a report from Bloomberg News, Roche Holding AG has … Continue reading

Posted in Accutane, Pharmaceuticals | Tagged |

Accutane Associated with Double Risk of Eye Disorders

A new study has associated the acne medication Accutane (isotretinoin) with an increased chance of developing some form of eye disorder. According to a report from HealthDay News, researchers at Tel Aviv Medical Center in Israel have found that people … Continue reading

Posted in Accutane, Pharmaceuticals | Tagged |

SOL Clock on Drug Lawsuit Doesn’t Start with FDA Warnings, NJ Court Rules

The New Jersey Supreme Court has upheld a lower court’s ruling that Food and Drug Administration (FDA) warnings about the dangers of prescription drugs do not always “start the clock” on the statute of limitations for product liability claims. According … Continue reading

Posted in Accutane, Legal News, Pharmaceuticals |

Accutane Trial Ends With $2 Million Verdict for One Plaintiff

Another < "http://www.yourlawyer.com/topics/overview/accutane_ibd">Accutane trial has ended with a win for a plaintiff. The Street said that the six-week trial resulted in a $2 million award for one of three plaintiffs after their attorneys argued that Roche, the maker of Accutane, … Continue reading

Posted in Pharmaceuticals |

Stevens-Johnson Syndrome Follows Teen’s Use of Eye Drops

A 19-year-old girl in the United Kingdom required weeks of intensive care treatment and is looking at months of follow-up treatment following a dangerous drug reaction called < "http://www.yourlawyer.com/topics/overview/stevens_johnson_syndrome">Stevens-Johnson syndrome after using Optrex eye drops. According to the Voice Online, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

Accutane Bowel Lawsuits in New Jersey Mass Tort Top 2400

There are now 2,441 < "http://www.yourlawyer.com/topics/overview/Accutane-Side-Effects-Inflammatory-Bowel-Disease-Colitis-Crohns-Disease-Lawyer-Lawsuit-Attorney">Accutane inflammatory bowel disease (IBD) lawsuits pending in a New Jersey mass tort litigation that began five years ago. Over the fall, more than 800 lawsuits were filed in the Accutane litigation, and it is … Continue reading

Posted in Accutane, Pharmaceuticals |

Accutane, Acne, Suicide Linked in New Study

A new Accutane study out of Sweden has linked the controversial acne drug to an increased risk of suicide. The study’s findings support increased mental health monitoring of patients for up to a year after taking Accutane. Approved by the … Continue reading

Posted in Accutane, Pharmaceuticals |

Accutane Puts Users At Risk For Intestinal Disorders

Inflammatory Bowel Disease (IBD)—Ulcerative Colitis and Crohn’s disease—are some of the dangerous side effects linked to Accutane. In 2005, the Accutane label was modified to warn that IBD had been associated its use; however, many believe the warning did not … Continue reading

Posted in Accutane, Pharmaceuticals |

400+ Accutane Lawsuits Filed in Past Two Months

More than 400 Accutane lawsuits alleging the acne drug caused a variety of side effects, including inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, have been filed in a New Jersey mass tort litigation over the past two months. … Continue reading

Posted in Accutane, Pharmaceuticals |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.